A Retrospective Observational Study Exploring 30- and 90-Day Outcomes for Patients With COVID-19 After Percutaneous Tracheostomy and Gastrostomy Placement.


Journal

Critical care medicine
ISSN: 1530-0293
Titre abrégé: Crit Care Med
Pays: United States
ID NLM: 0355501

Informations de publication

Date de publication:
01 05 2022
Historique:
pubmed: 19 2 2022
medline: 3 5 2022
entrez: 18 2 2022
Statut: ppublish

Résumé

To determine the 30- and 90-day outcomes of COVID-19 patients receiving tracheostomy and percutaneous endoscopic gastrostomy (PEG). Retrospective observational study. Multisite, inpatient. Hospitalized COVID-19 patients who received tracheostomy and PEG at four Boston hospitals. Tracheostomy and PEG placement. The primary outcome was mortality at 30 and 90 days post-procedure. Secondary outcomes included continued device presence, place of residence, complications, and rehospitalizations. Eighty-one COVID-19 patients with tracheostomy and PEG placement were included. At 90 days post-device placement, the mortality rate was 9.9%, 2.7% still had the tracheostomy, 32.9% still had the PEG, and 58.9% were at home. More than nine-in-10 patients in our population of COVID-19 patients who underwent tracheostomy and PEG were alive 90 days later and most were living at home. This study provides new information regarding the outcomes of this patient population that may serve as a step in guiding clinicians, patients, and families when making decisions regarding these devices.

Identifiants

pubmed: 35180721
doi: 10.1097/CCM.0000000000005451
pii: 00003246-202205000-00011
pmc: PMC9005100
doi:

Types de publication

Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

819-824

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2022 by the Society of Critical Care Medicine and Wolters Kluwer Health, Inc. All Rights Reserved.

Déclaration de conflit d'intérêts

Dr. Leiter received funding from the New England Journal of Medicine, New York University, the New York Times, and the United States Uniformed Services University. Dr. Mazzola received funding from The VeraMedica Institute LLC. The remaining authors have disclosed that they do not have any potential conflicts of interest.

Références

Johns Hopkins Coronavirus Resource Center: COVID-19 Map. 2020. Available at: https://coronavirus.jhu.edu/map.html . Accessed January 4, 2021
Richardson S, Hirsch JS, Narasimhan M, et al.; the Northwell COVID-19 Research Consortium: Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City Area. JAMA. 2020; 323:2052–2059
McCarthy CP, Murphy S, Jones-O’Connor M, et al.: Early clinical and sociodemographic experience with patients hospitalized with COVID-19 at a large American healthcare system. EClinicalMedicine. 2020; 26:100504
Armstrong RA, Kane AD, Cook TM: Outcomes from intensive care in patients with COVID-19: A systematic review and meta-analysis of observational studies. Anaesthesia. 2020; 75:1340–1349
Grasselli G, Greco M, Zanella A, et al.; COVID-19 Lombardy ICU Network: Risk factors associated with mortality among patients with COVID-19 in intensive care units in Lombardy, Italy. JAMA Intern Med. 2020; 180:1345–1355
Karagiannidis C, Mostert C, Hentschker C, et al.: Case characteristics, resource use, and outcomes of 10 021 patients with COVID-19 admitted to 920 German hospitals: An observational study. Lancet Respir Med. 2020; 8:853–862
Siempos II, Ntaidou TK, Filippidis FT, et al.: Effect of early versus late or no tracheostomy on mortality and pneumonia of critically ill patients receiving mechanical ventilation: A systematic review and meta-analysis. Lancet Respir Med. 2015; 3:150–158
Flaatten H, Gjerde S, Heimdal JH, et al.: The effect of tracheostomy on outcome in intensive care unit patients. Acta Anaesthesiol Scand. 2006; 50:92–98
Ferraro F, Gravina AG, d’Elia A, et al.: Percutaneous endoscopic gastrostomy for critically ill patients in a general intensive care unit. Acta Gastroenterol Belg. 2013; 76:306–310
Nobleza COS, Pandian V, Jasti R, et al.: Outcomes of tracheostomy with concomitant and delayed percutaneous endoscopic gastrostomy in the neuroscience critical care unit. J Intensive Care Med. 2019; 34:835–843
Grasselli G, Tonetti T, Protti A, et al.; collaborators: Pathophysiology of COVID-19-associated acute respiratory distress syndrome: A multicentre prospective observational study. Lancet Respir Med. 2020; 8:1201–1208
Bos LDJ: COVID-19-related acute respiratory distress syndrome: Not so atypical. Am J Respir Crit Care Med. 2020; 202:622–624
Hossein SM, Leili M, Hossein AM: Acceptability and outcomes of percutaneous endoscopic gastrostomy (PEG) tube placement and patient quality of life. Turk J Gastroenterol. 2011; 22:128–133
Oeyen SG, Vandijck DM, Benoit DD, et al.: Quality of life after intensive care: A systematic review of the literature. Crit Care Med. 2010; 38:2386–2400
Nalichowski R, Keogh D, Chueh HC, et al.: Calculating the benefits of a research patient data repository. AMIA Annu Symp Proc. 2006; 2006:1044
Deyo RA, Cherkin DC, Ciol MA: Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol. 1992; 45:613–619
Quan H, Sundararajan V, Halfon P, et al.: Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care. 2005; 43:1130–1139
Halfon P, Eggli Y, van Melle G, et al.: Measuring potentially avoidable hospital readmissions. J Clin Epidemiol. 2002; 55:573–587
Betancourt JR: Massachusetts General Hospital Annual Report on Equity in Health Care Quality. 2020. Available at: https://5536401f-20a1-4e61-a28e-914fb5dcef51.filesusr.com/ugd/888d39_6b0f9ebc637443abbb54207cf8dec427.pdf . Accessed August 1, 2021
Stokes EK, Zambrano LD, Anderson KN, et al.: Coronavirus disease 2019 case surveillance - United States, January 22-May 30, 2020. MMWR Morb Mortal Wkly Rep. 2020; 69:759–765
Bellani G, Laffey JG, Pham T, et al.; LUNG SAFE Investigators; ESICM Trials Group: Epidemiology, patterns of care, and mortality for patients with acute respiratory distress syndrome in intensive care units in 50 countries. JAMA. 2016; 315:788–800
Scales DC, Thiruchelvam D, Kiss A, et al.: The effect of tracheostomy timing during critical illness on long-term survival. Crit Care Med. 2008; 36:2547–2557
Kerckoffs M, Brinkman A, Keizer N, et al.: The performance of acute verses antecedent patient characteristics for 1-year mortality prediction during intensive care unit admission: A national cohort study. Crit Care. 2020; 24:330

Auteurs

Stephanie B Kiser (SB)

Division of Palliative Care and Geriatric Medicine, Department of Medicine, Massachusetts General Hospital, Boston, MA.

Kate Sciacca (K)

Division of Palliative Medicine, Department of Medicine, Brigham and Women's Hospital, Boston, MA.
Department of Psychosocial Oncology and Palliative Care, Dana-Farber Cancer Institute, Boston, MA.

Nelia Jain (N)

Division of Palliative Medicine, Department of Medicine, Brigham and Women's Hospital, Boston, MA.
Department of Psychosocial Oncology and Palliative Care, Dana-Farber Cancer Institute, Boston, MA.

Richard Leiter (R)

Division of Palliative Medicine, Department of Medicine, Brigham and Women's Hospital, Boston, MA.
Department of Psychosocial Oncology and Palliative Care, Dana-Farber Cancer Institute, Boston, MA.

Emanuele Mazzola (E)

Division of Palliative Care and Geriatric Medicine, Department of Medicine, Massachusetts General Hospital, Boston, MA.

Samantha Gelfand (S)

Division of Palliative Medicine, Department of Medicine, Brigham and Women's Hospital, Boston, MA.
Department of Psychosocial Oncology and Palliative Care, Dana-Farber Cancer Institute, Boston, MA.
Division of Renal Medicine, Department of Medicine, Brigham and Women's Hospital, Boston, MA.

Jonathan Jehle (J)

Division of Palliative Medicine, Department of Medicine, Brigham and Women's Hospital, Boston, MA.
Department of Psychosocial Oncology and Palliative Care, Dana-Farber Cancer Institute, Boston, MA.

Rachelle Bernacki (R)

Division of Palliative Medicine, Department of Medicine, Brigham and Women's Hospital, Boston, MA.
Department of Psychosocial Oncology and Palliative Care, Dana-Farber Cancer Institute, Boston, MA.

Daniela Lamas (D)

Division of Palliative Medicine, Department of Medicine, Brigham and Women's Hospital, Boston, MA.
Division of Pulmonary and Critical Care Medicine, Department of Medicine, Brigham and Women's Hospital, Boston, MA.

Zara Cooper (Z)

Division of Palliative Medicine, Department of Medicine, Brigham and Women's Hospital, Boston, MA.
Division of Trauma, Burn, and Surgical Critical Care, Department of Surgery, Brigham and Women's Hospital, Boston, MA.

Joshua R Lakin (JR)

Division of Palliative Medicine, Department of Medicine, Brigham and Women's Hospital, Boston, MA.
Department of Psychosocial Oncology and Palliative Care, Dana-Farber Cancer Institute, Boston, MA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH